Profile
Full Name
Inhibrx Biosciences, Inc.Ticker Symbol
INBXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 4, 2024Indexes
Not includedWebsite
http://inhibrx.comEmployees
156Key Details
Price
$11.47(-2.71%)
Market cap
$166.04M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$200.00K(-88.89% YoY)
Annual EPS
$112.62(+764.50% YoY)
PE ratio
0.10
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Inhibrx Biosciences doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 18, 25 Citizens Capital Markets
Market PerformJan 22, 25 JMP Securities
Market PerformJul 23, 24 JMP Securities
Market PerformJan 23, 24 JMP Securities
Market PerformNov 20, 23 JMP Securities
Market OutperformAug 23, 23 JMP Securities
OutperformMay 10, 23 JMP Securities
Market OutperformMar 8, 23 JMP Securities
Market OutperformMar 7, 23 Credit Suisse
OutperformNov 8, 22 Credit Suisse
OutperformInstitutional Ownership
- What is the ticker symbol for Inhibrx Biosciences?
- Does Inhibrx Biosciences pay dividends?
- What sector is Inhibrx Biosciences in?
- What industry is Inhibrx Biosciences in?
- What country is Inhibrx Biosciences based in?
- When did Inhibrx Biosciences go public?
- Is Inhibrx Biosciences in the S&P 500?
- Is Inhibrx Biosciences in the NASDAQ 100?
- Is Inhibrx Biosciences in the Dow Jones?
- When was Inhibrx Biosciences's last earnings report?
- When does Inhibrx Biosciences report earnings?
- Should I buy Inhibrx Biosciences stock now?
What is the ticker symbol for Inhibrx Biosciences?
The ticker symbol for Inhibrx Biosciences is NASDAQ:INBX
Does Inhibrx Biosciences pay dividends?
No, Inhibrx Biosciences does not pay dividends
What sector is Inhibrx Biosciences in?
Inhibrx Biosciences is in the Healthcare sector
What industry is Inhibrx Biosciences in?
Inhibrx Biosciences is in the Biotechnology industry
What country is Inhibrx Biosciences based in?
Inhibrx Biosciences is headquartered in United States
When did Inhibrx Biosciences go public?
Inhibrx Biosciences's initial public offering (IPO) was on June 4, 2024
Is Inhibrx Biosciences in the S&P 500?
No, Inhibrx Biosciences is not included in the S&P 500 index
Is Inhibrx Biosciences in the NASDAQ 100?
No, Inhibrx Biosciences is not included in the NASDAQ 100 index
Is Inhibrx Biosciences in the Dow Jones?
No, Inhibrx Biosciences is not included in the Dow Jones index
When was Inhibrx Biosciences's last earnings report?
Inhibrx Biosciences's most recent earnings report was on Mar 17, 2025
When does Inhibrx Biosciences report earnings?
The next expected earnings date for Inhibrx Biosciences is May 30, 2025
Should I buy Inhibrx Biosciences stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions